Non-steroidal anti-inflammatory drugs and cardiovascular risk : a rheumatologist's reply

Whitelaw, David (Health and Medical Publishing Group (HMPG), 2007-12)

Letter

The original publication is available at http://www.samj.org.za

Letter

To the Editor: The cyclo-oxygenase-2 (COX-2) inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs) have been the subject of scrutiny generated mainly by evidence suggesting that rofecoxib is associated with increased cardiovascular risk. Chin and Commerford1 have summarised some of the large volume of data; however, a critical review of published work yields interesting insights.

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/7803
This item appears in the following collections: